Abstract
Summary
LPI (LP Information)' newest research report, the “Immune Supplements Industry Forecast” looks at past sales and reviews total world Immune Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Immune Supplements sales for 2023 through 2029. With Immune Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Supplements industry.
This Insight Report provides a comprehensive analysis of the global Immune Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immune Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Supplements.
The global Immune Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immune Supplements players cover Qivaro, BYHWALTH, APOLLO, Swisse, Amway, GNC, ORTHOMOL, Blackmores and Conba, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid
Capsule
Powder
Others
Segmentation by application
Children
Aldult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Qivaro
BYHWALTH
APOLLO
Swisse
Amway
GNC
ORTHOMOL
Blackmores
Conba
Abbott
Puritan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Immune Supplements market?
What factors are driving Immune Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Supplements market opportunities vary by end market size?
How does Immune Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Immune Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immune Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Supplements.
The global Immune Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immune Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immune Supplements players cover Qivaro, BYHWALTH, APOLLO, Swisse, Amway, GNC, ORTHOMOL, Blackmores and Conba, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid
Capsule
Powder
Others
Segmentation by application
Children
Aldult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Qivaro
BYHWALTH
APOLLO
Swisse
Amway
GNC
ORTHOMOL
Blackmores
Conba
Abbott
Puritan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Immune Supplements market?
What factors are driving Immune Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Supplements market opportunities vary by end market size?
How does Immune Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immune Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Immune Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Immune Supplements by Country/Region, 2018, 2022 & 2029
2.2 Immune Supplements Segment by Type
2.2.1 Liquid
2.2.2 Capsule
2.2.3 Powder
2.2.4 Others
2.3 Immune Supplements Sales by Type
2.3.1 Global Immune Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Immune Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Immune Supplements Sale Price by Type (2018-2023)
2.4 Immune Supplements Segment by Application
2.4.1 Children
2.4.2 Aldult
2.5 Immune Supplements Sales by Application
2.5.1 Global Immune Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Immune Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Immune Supplements Sale Price by Application (2018-2023)
3 Global Immune Supplements by Company
3.1 Global Immune Supplements Breakdown Data by Company
3.1.1 Global Immune Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Immune Supplements Sales Market Share by Company (2018-2023)
3.2 Global Immune Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Immune Supplements Revenue by Company (2018-2023)
3.2.2 Global Immune Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Immune Supplements Sale Price by Company
3.4 Key Manufacturers Immune Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Supplements Product Location Distribution
3.4.2 Players Immune Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Immune Supplements by Geographic Region
4.1 World Historic Immune Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Immune Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Immune Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Immune Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Immune Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Immune Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Immune Supplements Sales Growth
4.4 APAC Immune Supplements Sales Growth
4.5 Europe Immune Supplements Sales Growth
4.6 Middle East & Africa Immune Supplements Sales Growth
5 Americas
5.1 Americas Immune Supplements Sales by Country
5.1.1 Americas Immune Supplements Sales by Country (2018-2023)
5.1.2 Americas Immune Supplements Revenue by Country (2018-2023)
5.2 Americas Immune Supplements Sales by Type
5.3 Americas Immune Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Supplements Sales by Region
6.1.1 APAC Immune Supplements Sales by Region (2018-2023)
6.1.2 APAC Immune Supplements Revenue by Region (2018-2023)
6.2 APAC Immune Supplements Sales by Type
6.3 APAC Immune Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Immune Supplements by Country
7.1.1 Europe Immune Supplements Sales by Country (2018-2023)
7.1.2 Europe Immune Supplements Revenue by Country (2018-2023)
7.2 Europe Immune Supplements Sales by Type
7.3 Europe Immune Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immune Supplements by Country
8.1.1 Middle East & Africa Immune Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Immune Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Immune Supplements Sales by Type
8.3 Middle East & Africa Immune Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Supplements
10.3 Manufacturing Process Analysis of Immune Supplements
10.4 Industry Chain Structure of Immune Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Supplements Distributors
11.3 Immune Supplements Customer
12 World Forecast Review for Immune Supplements by Geographic Region
12.1 Global Immune Supplements Market Size Forecast by Region
12.1.1 Global Immune Supplements Forecast by Region (2024-2029)
12.1.2 Global Immune Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Supplements Forecast by Type
12.7 Global Immune Supplements Forecast by Application
13 Key Players Analysis
13.1 Qivaro
13.1.1 Qivaro Company Information
13.1.2 Qivaro Immune Supplements Product Portfolios and Specifications
13.1.3 Qivaro Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Qivaro Main Business Overview
13.1.5 Qivaro Latest Developments
13.2 BYHWALTH
13.2.1 BYHWALTH Company Information
13.2.2 BYHWALTH Immune Supplements Product Portfolios and Specifications
13.2.3 BYHWALTH Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BYHWALTH Main Business Overview
13.2.5 BYHWALTH Latest Developments
13.3 APOLLO
13.3.1 APOLLO Company Information
13.3.2 APOLLO Immune Supplements Product Portfolios and Specifications
13.3.3 APOLLO Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 APOLLO Main Business Overview
13.3.5 APOLLO Latest Developments
13.4 Swisse
13.4.1 Swisse Company Information
13.4.2 Swisse Immune Supplements Product Portfolios and Specifications
13.4.3 Swisse Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Swisse Main Business Overview
13.4.5 Swisse Latest Developments
13.5 Amway
13.5.1 Amway Company Information
13.5.2 Amway Immune Supplements Product Portfolios and Specifications
13.5.3 Amway Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Amway Main Business Overview
13.5.5 Amway Latest Developments
13.6 GNC
13.6.1 GNC Company Information
13.6.2 GNC Immune Supplements Product Portfolios and Specifications
13.6.3 GNC Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GNC Main Business Overview
13.6.5 GNC Latest Developments
13.7 ORTHOMOL
13.7.1 ORTHOMOL Company Information
13.7.2 ORTHOMOL Immune Supplements Product Portfolios and Specifications
13.7.3 ORTHOMOL Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ORTHOMOL Main Business Overview
13.7.5 ORTHOMOL Latest Developments
13.8 Blackmores
13.8.1 Blackmores Company Information
13.8.2 Blackmores Immune Supplements Product Portfolios and Specifications
13.8.3 Blackmores Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Blackmores Main Business Overview
13.8.5 Blackmores Latest Developments
13.9 Conba
13.9.1 Conba Company Information
13.9.2 Conba Immune Supplements Product Portfolios and Specifications
13.9.3 Conba Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Conba Main Business Overview
13.9.5 Conba Latest Developments
13.10 Abbott
13.10.1 Abbott Company Information
13.10.2 Abbott Immune Supplements Product Portfolios and Specifications
13.10.3 Abbott Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbott Main Business Overview
13.10.5 Abbott Latest Developments
13.11 Puritan
13.11.1 Puritan Company Information
13.11.2 Puritan Immune Supplements Product Portfolios and Specifications
13.11.3 Puritan Immune Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Puritan Main Business Overview
13.11.5 Puritan Latest Developments
14 Research Findings and Conclusion